Search Results - Lutz Naehrlich

Refine Results
  1. 1
    Success of the German Cystic Fibrosis Registry

    Success of the German Cystic Fibrosis Registry by Lutz Naehrlich, Manuel Burkhart

    Published 2025
    Get full text
    Artigo
    Save to List
    Saved in:
  2. 2
    Cystic Fibrosis

    Cystic Fibrosis by Susanne Naehrig, Cho‐Ming Chao, Lutz Naehrlich

    Published 2017
    Get full text
    Revisão
    Save to List
    Saved in:
  3. 3
    Risk factors for respiratory Aspergillus fumigatus in German Cystic Fibrosis patients and impact on lung function

    Risk factors for respiratory Aspergillus fumigatus in German Cystic Fibrosis patients and impact on lung function by Uta Düesberg, J. Wosniok, Lutz Naehrlich, Patience Eschenhagen, C. Schwarz

    Published 2020
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  4. 4
    Use of elexacaftor/tezacaftor/ivacaftor leads to changes in detection frequencies of Staphylococcus aureus and Pseudomonas aeruginosa dependent on age and lung function in people with cystic fibrosis

    Use of elexacaftor/tezacaftor/ivacaftor leads to changes in detection frequencies of Staphylococcus aureus and Pseudomonas aeruginosa dependent on age and lung function in people w... by Anna‐Maria Dittrich, Sarah Sieber, Lutz Naehrlich, Manuel Burkhart, Sylvia Hafkemeyer, Burkhard Tümmler

    Published 2023
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    Cystic fibrosis in Europe: improved lung function and longevity – reasons for cautious optimism, but challenges remain

    Cystic fibrosis in Europe: improved lung function and longevity – reasons for cautious optimism, but challenges remain by Eitan Kerem, Annalisa Orenti, Arianna Adamoli, Elpis Hatziagorou, Lutz Naehrlich, Isabelle Sermet‐Gaudelus

    Published 2024
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    Serine Proteases Degrade Airway Mucins in Cystic Fibrosis

    Serine Proteases Degrade Airway Mucins in Cystic Fibrosis by Markus O. Henke, Gerrit John, Christina Rheineck, Shashi Chillappagari, Lutz Naehrlich, Bruce K. Rubin

    Published 2011
    Get full text
    Artigo
    Save to List
    Saved in:
  7. 7
    Assessment of pathologic increase in liver stiffness enables earlier diagnosis of CFLD: Results from a prospective longitudinal cohort study

    Assessment of pathologic increase in liver stiffness enables earlier diagnosis of CFLD: Results from a prospective longitudinal cohort study by V Klotter, Caroline Gunchick, E Siemers, Timo Räth, Helge Hudel, Lutz Naehrlich, M Roderfeld, Elke Roeb

    Published 2017
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    Progress of personalized medicine of cystic fibrosis in the times of efficient CFTR modulators

    Progress of personalized medicine of cystic fibrosis in the times of efficient CFTR modulators by Burkhard Tümmler, Sophia T. Pallenberg, Anna‐Maria Dittrich, Simon Y. Graeber, Lutz Naehrlich, Olaf Sommerburg, Marcus Mall

    Published 2025
    Get full text
    Revisão
    Save to List
    Saved in:
  9. 9
    Impact of COVID-19 on people with cystic fibrosis

    Impact of COVID-19 on people with cystic fibrosis by Carla Colombo, Pierre‐Régis Burgel, Silvia Gärtner, Silke van Koningsbruggen‐Rietschel, Lutz Naehrlich, Isabelle Sermet‐Gaudelus, Kevin W Southern

    Published 2020
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  10. 10
    Prevalence of meconium ileus marks the severity of mutations of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) gene

    Prevalence of meconium ileus marks the severity of mutations of the Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) gene by Annie Dupuis, Katherine Keenan, Chee Y. Ooi, Ruslan Dorfman, Marci K. Sontag, Lutz Naehrlich, Carlo Castellani, Lisa J. Strug, Johanna M. Rommens, Tanja Gonska

    Published 2015
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  11. 11
    Survival estimates in European cystic fibrosis patients and the impact of socioeconomic factors: a retrospective registry cohort study

    Survival estimates in European cystic fibrosis patients and the impact of socioeconomic factors: a retrospective registry cohort study by Edward F. McKone, Cono Ariti, Abaigeal Jackson, Anna Zolin, S.B. Carr, Annalisa Orenti, Jacqui G. van Rens, Lydie Lemonnier, Milan Maçek, Ruth H. Keogh, Lutz Naehrlich

    Published 2021
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  12. 12
    High Variability in Oral Glucose Tolerance among 1,128 Patients with Cystic Fibrosis: A Multicenter Screening Study

    High Variability in Oral Glucose Tolerance among 1,128 Patients with Cystic Fibrosis: A Multicenter Screening Study by Nicole Scheuing, Reinhard W. Holl, G Dockter, Julia M. Hermann, Sibylle Junge, Cordula Koerner‐Rettberg, Lutz Naehrlich, Christina Smaczny, Doris Staab, G. Thalhammer, Silke van Koningsbruggen‐Rietschel, Manfred Ballmann

    Published 2014
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  13. 13
    Hermansky-Pudlak syndrome type 2 manifests with fibrosing lung disease early in childhood

    Hermansky-Pudlak syndrome type 2 manifests with fibrosing lung disease early in childhood by Meike Hengst, Lutz Naehrlich, Poornima Mahavadi, Joerg Große-Onnebrink, Suzanne Terheggen‐Lagro, Lars Høsøien Skanke, Luise A. Schuch, Frank Brasch, Andreas Güenther, Simone Reu, Julia Ley‐Zaporozhan, Matthias Griese

    Published 2018
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  14. 14
    A phase 3, double-blind, parallel-group study to evaluate the efficacy and safety of tezacaftor in combination with ivacaftor in participants 6 through 11 years of age with cystic fibrosis homozygous for F508del or heterozygous for the F508del-CFTR mutation and a residual function mutation

    A phase 3, double-blind, parallel-group study to evaluate the efficacy and safety of tezacaftor in combination with ivacaftor in participants 6 through 11 years of age with cystic... by Jane C. Davies, Isabelle Sermet‐Gaudelus, Lutz Naehrlich, R. Scott Harris, Daniel Campbell, Neil Ahluwalia, Christopher Short, Eric L. Haseltine, Paul Panorchan, Clare Saunders, Caroline A. Owen, Claire Wainwright

    Published 2020
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  15. 15
    Concordant genotype of upper and lower airways P aeruginosa and S aureus isolates in cystic fibrosis

    Concordant genotype of upper and lower airways P aeruginosa and S aureus isolates in cystic fibrosis by Jochen G. Mainz, Lutz Naehrlich, M. Schien, M. Käding, Ian Schiller, Susanne Mayr, G Schneider, B. Wiedemann, Lutz Wiehlmann, Nina Cramer, W. Pfister, Barbara C. Kahl, James F. Beck, Burkhard Tümmler

    Published 2009
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  16. 16
    Elexacaftor-Tezacaftor-Ivacaftor Treatment Reduces Abdominal Symptoms in Cystic Fibrosis-Early results Obtained With the CF-Specific CFAbd-Score

    Elexacaftor-Tezacaftor-Ivacaftor Treatment Reduces Abdominal Symptoms in Cystic Fibrosis-Early results Obtained With the CF-Specific CFAbd-Score by Jochen G. Mainz, Carlos Zagoya, Louise Polte, Lutz Naehrlich, Lenny Sasse, Olaf Eickmeier, Christina Smaczny, Anton Barucha, Lilith Bechinger, Franziska Duckstein, Ludwik Kurzidim, Patience Eschenhagen, L.R. Caley, D. Peckham, C. Schwarz

    Published 2022
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  17. 17
    Impact of elexacaftor/tezacaftor/ivacaftor therapy on lung clearance index and magnetic resonance imaging in children with cystic fibrosis and one or two<i>F508del</i>alleles

    Impact of elexacaftor/tezacaftor/ivacaftor therapy on lung clearance index and magnetic resonance imaging in children with cystic fibrosis and one or two<i>F508del</i>alleles by Mirjam Stahl, Martha Dohna, Simon Y. Graeber, Olaf Sommerburg, Diane M. Renz, Sophia T. Pallenberg, Andreas Voskrebenzev, Katharina Schütz, Gesine Hansen, Felix Doellinger, Eva Steinke, Stephanie Thee, Jobst Röhmel, Sandra Barth, Claudia Rückes-Nilges, Julian Berges, Susanne Hämmerling, Mark O. Wielpütz, Lutz Naehrlich, Jens Vogel‐Claussen, Burkhard Tümmler, Marcus Mall, Anna‐Maria Dittrich

    Published 2024
    Get full text
    Artigo
    Save to List
    Saved in:
  18. 18
    Clinical characteristics of SARS-CoV-2 infection in children with cystic fibrosis: An international observational study

    Clinical characteristics of SARS-CoV-2 infection in children with cystic fibrosis: An international observational study by Robert Bain, Rebecca Cosgriff, Marco Zampoli, Alexander Elbert, Pierre‐Régis Burgel, S.B. Carr, Claudio Castaños, Carla Colombo, Harriet Corvol, Albert Faro, Christopher H. Goss, Hector Gutierrez, Andreas Jung, N. Kashirskaya, Bruce C. Marshall, Joel Melo, Pedro Mondéjar-López, Isabelle de Monestrol, Lutz Naehrlich, Rita Padoan, María Dolores Pastor‐Vivero, Samar Rizvi, Marco Salvatore, Luiz Vicente Ribeiro Ferreira da Silva Filho, K. Brownlee, Iram Haq, Malcolm Brodlie

    Published 2020
    Get full text
    Artigo
    Save to List
    Saved in:
  19. 19
    Changing epidemiology of the respiratory bacteriology of patients with cystic fibrosis–data from the European cystic fibrosis society patient registry

    Changing epidemiology of the respiratory bacteriology of patients with cystic fibrosis–data from the European cystic fibrosis society patient registry by Elpis Hatziagorou, Annalisa Orenti, Pavel Dřevı́nek, N. Kashirskaya, Meir Mei‐Zahav, K. De Boeck, Andreas Pfleger, Muriel Thomas Sciensano, Elise Lammertyn, Milan Maçek, Hanne Vebert Olesen, Anne Farge, Lutz Naehrlich, Rita Újhelyi, G. Fletcher, Rita Padoan, Zane Timpare, Kęstutis Malakauskas, Stojka Fustik, Vincent Gulmans, O. Turcu, L. Pereira, S. Mosescu, Milan Rodić, H. Kayserová, Uroš Krivec, Carlos Vázquez-Cordero, Isabelle de Monestrol, Anders Lindblad, Andreas Jung, Halyna Makukh, S.B. Carr, Rebecca Cosgriff, Anna Zolin

    Published 2019
    Get full text
    Artigo
    Save to List
    Saved in:
  20. 20
    Impact of COVID-19 infection on lung function and nutritional status amongst individuals with cystic fibrosis: A global cohort study

    Impact of COVID-19 infection on lung function and nutritional status amongst individuals with cystic fibrosis: A global cohort study by Julie Semenchuk, Yumi Naito, Susan C. Charman, S.B. Carr, Stephanie Y. Cheng, Bruce C. Marshall, Albert Faro, Alexander Elbert, Hector Gutierrez, Christopher H. Goss, Bülent Karadağ, Pierre‐Régis Burgel, Carla Colombo, Marco Salvatore, Rita Padoan, Géraldine Daneau, Satenik Harutyunyan, N. Kashirskaya, L. Kirwan, Peter G. Middleton, Rasa Ruseckaite, Isabelle de Monestrol, Lutz Naehrlich, Pedro Mondéjar-López, Andreas Jung, J. van Rens, Egil Bakkeheim, Annalisa Orenti, Domenique D. Zomer-van Ommen, Luiz Vicente Rf da Silva-Filho, Flávia Fonseca Fernandes, Marco Zampoli, Anne L. Stephenson

    Published 2024
    Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: